Chandrakant Vallabhaji Gogri files SEBI Takeover Regulation 31(4) substantial acquisition disclosure for Aarti Pharmalabs Limited

M&A / JV 22 Jun 2026 · Filed / open· ✓ Verified

Chandrakant Vallabhaji Gogri submitted to NSE a copy of the Regulation 31(4) disclosure required under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This disclosure is mandated when a person crosses 25% or such other thresholds of voting rights in a listed company. The filing date is 22 June 2026. No consideration amount, number of shares acquired, or acquisition price is stated in the available document reference.

Why it mattersThe filing triggers mandatory transparency obligations under the SEBI Takeover Code; the acquirer's intent, funding source, and any connected-party relationships must be disclosed to the market and target board within prescribed timeframes.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals